Differential modulation of etazolate or pentobarbital enhanced [3H] muscimol binding by benzodiazepine agonists and inverse agonists.
P A Borea, P Supavilai, M Karobath
Index: Brain Res. 280(2) , 383-6, (1983)
Full Text: HTML
Abstract
Flunitrazepam, a benzodiazepine agonist increases, and DMCM, an inverse agonist decreases the stimulation by etazolate or pentobarbital of [3H] muscimol binding to membranes of rat cerebral cortex. Ro 15-1788 has no marked effects but antagonizes the action of both flunitrazepam and DMCM. The investigation of several drugs acting on benzodiazepine receptors on etazolate enhancement of [3H] muscimol binding suggests that their receptor interaction reflects a spectrum from agonists to inverse agonists.
Related Compounds
Related Articles:
Etazolate improves performance in a foraging and homing task in aged rats.
2010-05-25
[Eur. J. Pharmacol. 634(1-3) , 95-100, (2010)]
Physostigmine inhibition of 3',5'-cyclic AMP phosphodiesterase from cat sciatic nerve.
1984-03-01
[J. Pharmacol. Exp. Ther. 228(3) , 656-61, (1984)]
[Pharmacologic value of cyclic nucleotide phosphodiesterase inhibitors].
1984-01-01
[Ann. Pharm. Fr. 42(2) , 99-112, (1984)]
TcPDE4, a novel membrane-associated cAMP-specific phosphodiesterase from Trypanosoma cruzi.
2006-01-01
[Mol. Biochem. Parasitol. 145(1) , 40-9, (2006)]
1987-11-01
[J. Neurochem. 49(5) , 1491-7, (1987)]